Tempest Therapeutics Inc (NASDAQ:TPST) has a beta value of -1.67 and has seen 0.76 million shares traded in the recent trading session. The company, currently valued at $41.72M, closed the recent trade at $0.96 per share which meant it gained $0.01 on the day or 0.70% during that session. The TPST stock price is -525.0% off its 52-week high price of $6.00 and 27.08% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.17 million shares traded. The 3-month trading volume is 3.91 million shares.
The consensus among analysts is that Tempest Therapeutics Inc (TPST) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.25.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Sporting 0.70% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TPST stock price touched $0.96 or saw a rise of 8.57%. Year-to-date, Tempest Therapeutics Inc shares have moved 14.54%, while the 5-day performance has seen it change 14.04%. Over the past 30 days, the shares of Tempest Therapeutics Inc (NASDAQ:TPST) have changed 8.97%. Short interest in the company has seen 2.64 million shares shorted with days to cover at 0.39.
Tempest Therapeutics Inc (TPST) estimates and forecasts
Figures show that Tempest Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -55.54% over the past 6 months, with this year growth rate of 27.23%, compared to 16.70% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 62.66% over the past 5 years.
TPST Dividends
Tempest Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tempest Therapeutics Inc (NASDAQ:TPST)’s Major holders
Insiders own 0.24% of the company shares, while shares held by institutions stand at 23.02% with a share float percentage of 23.07%. Investors are also buoyed by the number of investors in a company, with Tempest Therapeutics Inc having a total of 30.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 0.55 million shares worth more than $1.21 million. As of 2024-06-30, BLACKROCK INC. held 2.4747% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 0.43 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.95 million and represent 1.9426% of shares outstanding.
